Molecular basis of EWS interdomain self‐association and its role in condensate formation
Open Access
- 22 September 2025
- journal article
- Published by Wiley in Protein Science
- Vol. 34 (10) , e70316
Abstract
Ewing sarcoma, the second most common pediatric bone and soft tissue cancer, is caused by aberrant fusion of the RNA‐binding protein EWS (EWS) low‐complexity domain (EWSLCD) to the DNA‐binding domain of the transcription factor friend leukemia integration 1 (FLI1). The resulting fusion, EWS::FLI1, directly interacts with and engages in a dynamic interplay with EWS that drives tumorigenesis and regulates the function of both proteins. While EWSLCD is known to promote self‐association, the role of the RNA‐binding domains (RBDs) of EWS, which include arginine–glycine–glycine (RGG) repeat regions and a structured RNA‐recognition motif (RRM), remains less well understood. Here, we investigate the interplay between EWSLCD and RBDs using biomolecular condensation assays, microscopy, nuclear magnetic resonance (NMR) spectroscopy, and molecular simulations. Our studies reveal that RBDs differentially influence EWSLCD condensate formation and suggest that electrostatics and polypeptide‐chain length likely contribute to this interaction. NMR spectroscopy and molecular dynamics simulations further demonstrate that EWSLCD and the central RNA‐binding region, comprising the RRM and RGG2 domains, engage in transient, non‐specific interactions that are broadly distributed across both regions and involve diverse residue types. Specifically, tyrosine, polar residues, and proline within EWSLCD preferentially interact with arginine, glycine, and proline residues in the RBD. Atomistic simulations of EWS confirm that the full‐length protein exhibits a similar interaction profile with conserved chemical specificity, supporting a model in which a network of weak, distributed interdomain contacts underlies EWS self‐association. Together, these findings provide molecular insight into the mechanisms of EWS condensate formation and lay the groundwork for understanding how interdomain interactions regulate EWS and EWS::FLI1 function.Keywords
All Related Versions
Funding Information
- Alex's Lemonade Stand Foundation for Childhood Cancer (1335092)
- Welch Foundation (A‐2113‐20220331)
- National Institutes of Health (R01GM140127, R35GM153338, F31CA295030, P30CA054174)
This publication has 60 references indexed in Scilit:
- RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domainsNucleic Acids Research, 2005
- Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion proteinOncogene, 2003
- EWS·Fli-1 Fusion Protein Interacts with Hyperphosphorylated RNA Polymerase II and Interferes with Serine-Arginine Protein-mediated RNA SplicingJournal of Biological Chemistry, 2000
- Transcriptional Activation by the Ewing's Sarcoma (EWS) Oncogene Can Be Cis-repressed by the EWS RNA-binding DomainJournal of Biological Chemistry, 2000
- Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activityOncogene, 1999
- Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase IIOncogene, 1998
- EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAF II 68, and Subunits of TFIID and RNA Polymerase II ComplexesMolecular and Cellular Biology, 1998
- Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.1995
- Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumoursNature, 1992
- CHROMOSOMAL TRANSLOCATION T(11-22) (Q24-Q12) IN CELL-LINES DERIVED FROM EWING SARCOMA1983